1. Parker SL, Tong T, Bolden S, et al. (1997) Cancer statistics, 1997. CA Cancer J. Clin. 47: 5–27.
2. Thorn M, Adami HA, Bergstrom R, et al. (1989) Trends in survival from malignant melanoma: Remarkable improvement in 23 years. J. Natl. Cancer Inst 81: 611–618.
3. Balch CM, Soong S, Shaw HM, et al. (1992) An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, et al. (eds). Cutaneous Melanoma. J.B. Lippincott, New York, pp. 165–187.
4. Bakker ABH, Marland G, deBoer AJ, et al. (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55: 5330–5334.
5. Kawakami Y, Robbins PF. (1995) Genes coding for tumor antigens recognized by T lymphocytes. In: DeVita VT, Jr., Hellman S, Rosenberg SA (eds). Biologic Therapy of Cancer. J. B. Lippincott, Philadelphia, pp. 53–64.